SCIENTIFIC BACKGROUND

PMP22

Charcto-Marie-Tooth (CMT) neuropathies are the most common hereditary peripheral neuropathies with clinical and genetic heterogeneity (prevalence approximately 1:3,300). The mode of inheritance is predominantly autosomal dominant, but can also be autosomal recessive or X-linked. The age of onset is the 1st to 3rd decade. Affected individuals typically show slowly progressive distal muscle (arms and legs) weakness and atrophy, often accompanied by mild to moderate sensory loss. In addition, decreased tendon reflexes and high arches can be observed.

 

CMT neuropathies are classified according to genetic, electrophysiological, and neuropathological criteria. The most common form is the autosomal dominant inherited CMT1 which accounts for 40-50% of all CMT neuropathies. It is divided into several subtypes depending on the affected gene and type of pathogenic variant, and 70%-85% of all CMT1 involve the CMT1A subtype. The genetic cause is a 1.5 MB tandem duplication on chromosome 17p11.2 (CMT1A duplication), that includes the PMP22 gene. In about one third of patients, it is a de novo duplication.

 

CMT1 is a predominantly motor, demyelinating peripheral polyneuropathy with distal paresis, especially of the lower limbs. Motor nerve conduction velocity is severely reduced (<38m/s). Approximately 20% of all patients with unclassified chronic peripheral neuropathy have CMT1A. A large study of German patients with the CMT1 phenotype found that CMT1A accounted for 51%, CMTX1 for 9%, and CMT1B for 5%. Molecular genetic testing of genes for these and other subtypes cantake place following exclusion of the typical CMT1A duplication (see also Hereditary Neuropathies).

 

References

Wu et al. 2017, Biomed Res Int  2017:6481367 / McGarth 2016, Clin Anat 29:547 / Gess et al. 2013, Nervenarzt 84:157 / Rautenstrauss et al. 2009, medgen 21:543 / Juarez et al. 2012, Neural Plast 2012:171636

GENES

PMP22

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Overview In January 2024, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) published new recommendation...

Read more

Endometriosis is a chronic gynecological condition that affects 1 in 10 women of reproductive age worldwide [1]. It can manifest with the first menst...

Read more

Rare Disease Day is a global awareness day held annually to raise awareness of all rare diseases. It was first celebrated in 2008, on the rarest day ...

Read more

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the...

Read more

In honor of the international day of women and girls in science, we interviewed one of our very own, Dr. Evelina Papaioannou. Dr. Evelina Pa...

Read more

Aneuploidies, such as translocations, whole or segmental chromosomal duplications, and deletions, are examples of chromosomal abnormalities that are ...

Read more